Apnimed, Inc. APMD
IPO
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | 125.94M | 67.72M | -69.47M | ||
| Total Depreciation and Amortization | 7.00K | 6.00K | 6.00K | ||
| Total Amortization of Deferred Charges | 2.85M | -- | -- | ||
| Total Other Non-Cash Items | -81.15M | 1.53M | 64.77M | ||
| Change in Net Operating Assets | -65.75M | -89.07M | -12.67M | ||
| Cash from Operations | -18.11M | -19.81M | -17.37M | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 99.66M | -- | -- | ||
| Cash from Investing | 99.66M | -- | -- | ||
| Total Debt Issued | 48.19M | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 45.00K | 16.00K | 36.00K | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | 0.00 | 25.00M | 16.50M | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -3.86M | -208.00K | -243.00K | ||
| Cash from Financing | 44.37M | 24.81M | 16.29M | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 125.92M | 5.00M | -1.08M | ||